BIO’s investment into ACEP Group’s operations in Burkina Faso, Cameroon, Madagascar, Niger, and Senegal for EUR 4.1 million

Lead party: Belgian Investment Company for Developing Countries (BIO) (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: ACEP Group (private company) · Sector: Financial Services, Microfinance Institutions · Countries of operation: Senegal, Niger, Burkina Faso, Cameroon, Madagascar Transaction type: Investment · Asset class: Private Equity · Strategy: Growth…


Lead party: Belgian Investment Company for Developing Countries (BIO) (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: ACEP Group (private company) · Sector: Financial Services, Microfinance Institutions · Countries of operation: Senegal, Niger, Burkina Faso, Cameroon, Madagascar

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$4.5m

Lead investor/buyer: Belgian Investment Company for Developing Countries (BIO) · Investors/buyers: Belgian Investment Company for Developing Countries (BIO)

Legal advisers: not identified in the source record.

Source: announced 14 October 2019. Original announcement: bio-invest.be.